Skip to content

    Ascendis Pharma A/S (ASND) stock price & financials

    View ASND earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+28.4% 1Y

    Financials

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY17FY18FY19FY20FY21FY23FY24FY25
    AssetsCash & Equivalents$234.28M$318.15M$671.91M$717.26M$505.44M$433.34M$581.31M$723.85M
    Short-Term Investments
    Total Current Assets$245.42M$335.38M$686.59M$908.22M$912.75M$776.51M$1.10B$1.30B
    Net PP&E$3.07M$4.95M$50.63M$132.66M$142.76M$122.25M$102.55M$172.11M
    Goodwill$4.19M$4.00M$3.93M
    Intangibles
    Total Assets$253.03M$365.22M$760.24M$1.20B$1.23B$912.27M$1.23B$1.53B
    LiabilitiesTotal Current Liabilities$28.50M$44.56M$53.91M$64.80M$113.66M$813.84M$943.18M$1.26B
    Short-Term Debt
    Long-Term Debt$110.96M$246.41M$379.28M$452.67M
    Long-Term Leases
    Total Liabilities$28.50M$44.56M$89.44M$173.12M$227.98M$1.07B$1.34B$1.72B
    EquityCommon Stock & APIC
    Retained Earnings
    Total Equity$224.52M$320.66M$670.80M$1.03B$1.00B-$161.00M-$109.82M-$191.31M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25
    ActivitiesCash from Operating-$158.93M-$197.65M-$333.22M-$473.03M-$528.71M-$516.43M-$318.11M$63.33M
    Cash from Investing-$3.03M-$5.80M-$357.33M-$125.24M$65.84M$316.55M$7.14M-$9.97M
    Cash from Financing$232.74M$554.50M$739.51M$397.98M$423.20M$148.39M$461.20M$42.69M
    SummaryCapital Expenditure-$3.03M-$5.80M-$24.37M-$26.85M-$15.45M-$2.70M
    Free Cash Flow-$161.96M-$203.44M-$357.59M-$499.88M-$544.17M-$519.13M
    FCF Margin-1336.8%-1354.0%-4191.1%-5674.4%-997.0%-176.1%

    Ratios